期刊文献+

新型斑蝥素羧酸衍生物的合成及其抗癌活性 被引量:5

Synthesis and Antitumor Activity of a Novel Cantharidin Carboxylic Derivative
在线阅读 下载PDF
导出
摘要 以DMSO为溶剂,5-氟脲嘧啶(5-Fu)为修饰物,对去甲斑蝥素(2)酸酐环部分进行结构修饰,合成了一个新型的去甲斑蝥素羧酸衍生物(3),其结构经1H NMR和IR表征。采用L9(34)正交试验考察了原料比,反应温度,反应时间及溶剂用量对反应的影响。结果表明,在最佳反应条件[2 0.5 mmol,n(2)∶n(5-Fu)=1.2,于140℃反应6 h,DMSO用量15 mL]下制备的3收率为78.2%。采用MTT法研究了体外3对人肝癌细胞HepG2的抑制活性。结果表明,3在用药量为250μmol·L-1时对HepG2的抑制率为89.5%,其IC50为232.4μmol·L-1。 A novel cantharidin carboxylic derivative(3) was synthesized by structural modification of norcantharidin(2) using 5-fluorouracil(5-Fu) as the modifier in DMSO.The structure was characterized by 1H NMR and IR.The effect of material ratio,reaction temperature,reaction time and solvent amount on reaction were investigated by L9 (34) orthogonal experiment.The yield of 3 was 78.2% under the optimum reaction conditions[2 was 0.5 mmol,n(2) ∶ n(5-Fu) was 1.2,DMSO was 15 mL,at 140 ℃ for 6 h].Antitumor activity of 3 was tested by MTT method.The results indicated that 3 exhibited good inhibition to HepG2 human cancer cells.Inhibition rate of 3 was 89.5% at 250 μmol · L-1,and IC50 was 232.4μmol · L-1.
出处 《合成化学》 CAS CSCD 北大核心 2013年第5期518-521,共4页 Chinese Journal of Synthetic Chemistry
基金 康缘中医药科技创新基金资助项目(HZ1006KY)
关键词 去甲斑蝥素 5-氟尿嘧啶 合成 抗癌活性 norcantharidin 5-fluorouracil synthesis antitumor activity
  • 相关文献

参考文献12

二级参考文献56

  • 1范跃祖,傅锦业,赵泽明,陈春球.去甲斑蝥素对原发性胆囊癌GBC-SD细胞系增殖和凋亡的影响[J].上海医学,2003,26(S1):1-4. 被引量:27
  • 2张宏娟,丁娅,张灿,沈健.O-羧甲基N-半乳糖化壳聚糖衍生物的设计、合成和表征[J].中国天然药物,2004,2(6):354-358. 被引量:8
  • 3张灿,丁娅,平其能.水溶性6-O-琥珀酰-N-半乳糖化壳聚糖衍生物的制备与表征[J].中国药科大学学报,2005,36(4):291-295. 被引量:21
  • 4梁文华 兰云军 等.-[J].中国皮革,1996,7:36-39.
  • 5Huh J E,Kang K S,Chae C,Kin H M,Ahn K S, Kim S H Roles of p38 and JNK mitogen-activated protein kinase path ways during cantharidin-induced apoptosis in U937 cells[J]. Biochem Pharmacol, 2004,67,1811-1818.
  • 6MeCuskey A, Keane M A, Mudgee L M, Sire A T, Sakoff J, Quinn R J. Anhydride modified cantharidin analogues. Is ring o pening important in the inhibition of protein phosphatase 2A [J]? EurJ Med Chem,2000,35:957-964.
  • 7Hill T A,Stewart S G,Ackland S P,Gilbert J ,Sauer B,Sakoff J A,et al. Norcantharimides, synthesis and anticancer activity:synthesis of new norcantharidin analogues and their anticancer evaluation[J]. Bioorg Med Chem, 2007,15 : 6126-6134.
  • 8McCluskey A,Bowyer M C, Collins E,Sim A T, Sakoff J A, Baldwin M I.. Anhydride modified eantharidin analogues: synthesis,inhibition of protein phosphatases 1 and 2A and anticancer activity[J]. Bioorg Med Chem Lett,2000,10:1687-1690.
  • 9Stewar S G,Hill T A,Gilbert J,Ackland S P,Sakoff J A,Mc Cluskey A. Synthesis and biological evaluation of norcantharidin analogues:towards PP1 selectivity[J]. Bioorg Med Chem, 2007,15 : 7301-7310.
  • 10Baba Y, Hirukawa N, Sodeoka M. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B(calcineurin) :implications for the binding mode[J]. Bioorg Med Chem, 2005,13 : 5164-5170.

共引文献72

同被引文献61

引证文献5

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部